Items tagged with Access
TB Alliance announces partnership with Remington Pharmaceuticals to commercialize new therapy for drug-resistant forms of TB in Pakistan (post)
NEW YORK (August 10, 2023)—Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license to market the anti-tuberculosis (TB) medicine pretomanid as part of the all-oral, six-month BPaL and BPaLM regimens for treatment of drug-resistant TB (comprised of bedaquiline, pretomanid, and linezolid, with or without moxifloxacin). Pakistan ranks third among countries designated by the World Health Organization as having a high burden of drug-resistant TB. Remington has agreed to develop, manufacture, and commercialize pretomanid in Pakistan and the collaboration may extend to other countries in the future.
Drug shortage shows Modi’s TB eradication dream needs more than just ambition (post)
In 2018, India articulated its noble ambition to eliminate TB by 2025, five years before the global target. But news reports show we aren’t even close to that goal.
Kyrgyzstan, Ukraine, and Uzbekistan update national guidelines for drug-resistant TB treatment to advance national rollout of three-drug, six-month regimen (post)
PRETORIA (September 18, 2023)—Kyrgyzstan, Ukraine, and Uzbekistan – participants in the LIFT-TB project – have updated their National Tuberculosis (TB) Clinical Guidelines to endorse the all-oral, six-month BPaL/M (bedaquiline + pretomanid + linezolid ± moxifloxacin) regimen(s) as the national standard for treating most patients with drug-resistant tuberculosis (DR-TB).
Johnson & Johnson under investigation in South Africa over 'excessive' drug prices (post)
U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country's antitrust regulator said Friday (15 September).
Bill & Melinda Gates Foundation doubles its contribution to Unitaid to US$100 million over 5 years (post)
21 September 2023: The Bill & Melinda Gates Foundation announced a long-term commitment of $100 million to Unitaid to bring faster access to health products in low- and middle-income countries. This funding doubles the foundation’s previous commitment and will support Unitaid’s work to accelerate the introduction and delivery of new lifesaving solutions at equitable scale, including those for maternal and newborn health.
Unitaid to partner with communities and civil society to drive access to new drug-resistant TB treatment regimens with new call for proposals (post)
Geneva, 20 September 2023 – As the United Nations General Assembly convenes world leaders at the High-Level Meeting on Tuberculosis (TB) this week, discussions will focus on the urgent need for access and innovation to put an end to a disease that we have known how to cure for decades. Despite this, TB continues to kill more people each year than any other infectious disease.
Patients’ rights groups accuse Union health ministry of denying shortages of key medicines for drug-resistant TB (post)
Patients’ rights groups have accused the Union health ministry of denying shortages of key medicines for drug-resistant tuberculosis (TB) even though they say the ministry’s own figures of drug inventories indicate why patients are facing shortages.
TB patients across India struggle with acute drug shortages, government denies but WHO worried (post)
New Delhi, 01/Oct/2023: In an unusual repetition of sorts, the Union health ministry issued a press release on Sunday, October 1, denying any shortages of essential medicines for drug-resistant TB patients. It was only on September 26 that the ministry issued an almost similar statement.
Johnson & Johnson lifts patent on MDR-TB drug but it may be years before South Africa benefits (post)
Pharmaceutical giant Johnson & Johnson (J&J) recently announced that it would lift patents on the life-saving drug bedaquiline.
New TB infections likely to increase, as Kenya runs out of supply of drugs (post)
Kenya is likely to lose gains made in the fight against TB, a leading infectious disease, following an acute shortage of drugs.
Page 50 of 83 · Total posts: 0
←First 49 50 51 Last→